Cargando…
Argininosuccinate lyase deficiency causes blood-brain barrier disruption via nitric oxide–mediated dysregulation of claudin expression
Nitric oxide (NO) is a critical signaling molecule that has been implicated in the pathogenesis of neurocognitive diseases. Both excessive and insufficient NO production have been linked to pathology. Previously, we have shown that argininosuccinate lyase deficiency (ASLD) is a novel model system to...
Autores principales: | Kho, Jordan, Polak, Urszula, Jiang, Ming-Ming, Odom, John D., Hunter, Jill V., Ali, Saima M., Burrage, Lindsay C., Nagamani, Sandesh C.S., Pautler, Robia G., Thompson, Hannah P., Urayama, Akihiko, Jin, Zixue, Lee, Brendan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544197/ https://www.ncbi.nlm.nih.gov/pubmed/37490345 http://dx.doi.org/10.1172/jci.insight.168475 |
Ejemplares similares
-
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
por: Syed, N, et al.
Publicado: (2013) -
Functional Characterization of Argininosuccinate Lyase Gene Variants by Mini-Gene Splicing Assay
por: Wang, Yanyun, et al.
Publicado: (2019) -
Refeeding syndrome in a young woman with argininosuccinate lyase deficiency()
por: Stuy, M., et al.
Publicado: (2015) -
Identification of mutations in Malaysian patients with argininosuccinate lyase (ASL) deficiency
por: Ali, Ernie Zuraida, et al.
Publicado: (2019) -
Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
por: Karvelsson, Sigurdur Trausti, et al.
Publicado: (2021)